# Immunotech Laboratories, Inc. (IMMB)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/IMMB/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2016 | $ 0 | $ -672.2K | N/A | $ 2.42M | $ 4.80M |
| 2006 | $ 4.5K | $ -53.63M | $ -382.8K | $ 483.7K | $ -2.09M |
| 2005 | $ 0 | $ -50.87M | $ -428.7K | $ 0 | $ -1.05M |
| 2004 | $ 0 | $ -373.2K | $ -56.7K | $ 37.5K | $ -625.7K |
| 2003 | $ 545.1K | $ -473.8K | $ -95.6K | $ 37.5K | $ -597.0K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.50 |
| Liabilities / Eq | 1.19 |
| Current Ratio | 0.00 |

## Other views

- [Metrics](https://sponda.capital/en/IMMB.md)
- [Charts](https://sponda.capital/en/IMMB/charts.md)
- [Compare](https://sponda.capital/en/IMMB/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.